文献速递类风湿关节炎

超声评估与临床疾病活动度评估在伴焦虑或抑郁的类风湿关节炎患者中的对比

Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depression.
PubMed 文献 · Semin Arthritis Rheum · 2024-06-28

焦虑/抑郁组与无焦虑/抑郁组的超声能量多普勒和灰阶总和评分相似,但复合疾病活动度评分、患者报告结局、ESR、CRP及血浆钙卫蛋白均显著更差。作者认为超声可能是评估此类患者的客观工具。

要点

  • 焦虑/抑郁组与无焦虑/抑郁组的超声能量多普勒和灰阶总和评分无显著差异。
  • 焦虑/抑郁组的复合疾病活动度评分及患者报告结局显著更差。
  • 作者认为超声检查可能是评估伴焦虑或抑郁的类风湿关节炎患者的客观工具。

核心结论

  • 本研究强调焦虑和抑郁对标准诊疗中类风湿关节炎患者的负面影响,并指出疾病活动度评估面临的挑战。
  • 作者认为超声检查可能是评估这些患者的有价值的客观工具。

研究设计与样本

  • 共纳入201例起始生物改善病情抗风湿药的类风湿关节炎患者(82%为女性,平均年龄52岁,病程10年)。
  • 通过EuroQoL-5D-3L问题「我没有/中度/极度焦虑或抑郁」识别焦虑或抑郁患者。
  • 对36个关节和4条肌腱进行超声评估,计算能量多普勒和灰阶总和评分(范围均为0-120)。

主要发现

  • 焦虑/抑郁组与无焦虑/抑郁组的中位(IQR)能量多普勒总和评分分别为13(4,21) vs 10(3,20),p=0.53。
  • 焦虑/抑郁组与无焦虑/抑郁组的中位(IQR)灰阶总和评分分别为28(18,42) vs 25(14,41),p=0.51。
  • 焦虑/抑郁组的复合疾病活动度评分显著更差(p<0.001),患者报告结局、ESR、CRP和血浆钙卫蛋白也显著更差(所有p≤0.02)。
  • 敏感性分析证实上述发现,但CRP除外;焦虑/抑郁组自报经济困难和睡眠困难也更差,未工作的比例更高(所有p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare disease activity as assessed by ultrasonography (US) between rheumatoid arthritis (RA) patients with and without anxiety or depression, and to compare clinical disease activity and sociodemographic measures between these patient groups. METHODS: Anxious or depressed patients were identified by EuroQoL-5D-3L question "I am not/moderately/extremely anxious or depressed." US assessments of 36 joints and 4 tendons were performed and power Doppler (PD) and grey scale (GS) sum scores calculated (both range 0-120). Comparisons between anxious/depressed and not anxious/depressed patients were performed in unadjusted analyses, adjusted logistic regression, and sensitivity analyses. RESULTS: A total of 201 RA patients starting biological disease-modifying antirheumatic drugs were included (82 % women, mean age 52 years, disease duration 10 years). Hundred-and-nine patients (54.2 %) were moderately or extremely anxious/depressed. Median (IQR) PD (13 (4, 21) vs. 10 (3, 20), p = 0.53) and GS (28 (18, 42) vs. 25 (14, 41), p = 0.51) sum scores were similar between anxious/depressed and not anxious/depressed patients, respectively, whereas composite scores of disease activity were significantly worse in the anxious/depressed patients (p < 0.001), as were also patient-reported outcomes, ESR, CRP and plasma calprotectin (all p ≤ 0.02). Sensitivity analyses confirmed these findings, except for CRP. Self-reported economy and sleep difficulties were also worse in the anxious/depressed patients and a higher proportion were not working (all p < 0.001). CONCLUSION: This study highlights the negative impact of anxiety and depression on RA patients in standard care, and underscores the challenges in disease activity assessment. US examination may be a valuable objective tool in the evaluation of these patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Michelsen B, Sexton J, Kvien TK, et al. Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depression. Semin Arthritis Rheum. 2024. PMID: 38972287. doi:10.1016/j.semarthrit.2024.152502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。